Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

Cancer Gene Therapy

Volumn 9, Issue 3, 2002, Pages 254-259

  Habib, Nagy ^a   Salama, Hosny ^b   Abu Median, Ahmed Abd El Latif ^b   Anis, Ilia Isac ^b   Al Aziz, Rasha Ahmed Abd ^b   Sarraf, Catherine ^a   Mitry, Ragai ^a   Havlik, Roman ^a   Seth, Prem ^c   Hartwigsen, Jack ^c   Bhushan, Reva ^c   Nicholls, Joanna ^a   Jensen, Steen ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CAIRO UNIVERSITY   (Egypt)

^c DES MOINES UNIVERSITY   (United States)

Author keywords

dl1520 adenovirus; Gene therapy; Hepatocellular carcinoma

Indexed keywords

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; AGED; CARCINOMA, HEPATOCELLULAR; ETHANOL; FEMALE; GENE DELETION; GENE THERAPY; GENES, P53; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

ALCOHOL; ANTINEOPLASTIC AGENT; LIVER ENZYME; ONYX 015; PROTEIN P53; UNCLASSIFIED DRUG;

ADENOVIRUS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; FEMALE; FEVER; GENE DELETION; GENE MUTATION; GENE THERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS MUTANT; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 85047699490     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700431     Document Type: Article

References (22)

1. Hepatobiliary cancers
2. Transactivation of cellular gene expression by hepatitis B viral proteins: A possible molecular mechanism of hepatocarcinogenesis
3. Physiological effects of hepatitis C
4. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
5. Surgical management of hepatocellular carcinoma: Resection or transplantation?
6. Surgical resection for small hepatocellular carcinoma
7. Hepatocellular carcinoma: Non surgical treatment
8. Clinical results of radiofrequency ablation in primary and secondary liver tumours
9. Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle
10. Tumour suppressor genes
11. The molecular genetics of cancer
12. P53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
13. An adenovirus mutant that replicates selectively in p53-deficient human tumour cells
14. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection
15. E1B deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumours
16. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
17. Treatment of hepatocellular carcinoma: Too many options?
18. A phase II trial of intratumoural injection with a selectively replicating adenovirus (ONYX-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck
19. Adenovirus-mediated p53 gene transfer in advanced non-small-cell cancer
20. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma
21. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma
22. Electron microscopic assessment of adenovirus-mediated transfer